These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13799542)

  • 1. Gross physical properties of emulsified influenza virus vaccines and the adjuvant response.
    BERLIN BS
    J Immunol; 1960 Jul; 85():81-9. PubMed ID: 13799542
    [No Abstract]   [Full Text] [Related]  

  • 2. Now and future influenza vaccines.
    Ruben FL
    Infect Dis Clin North Am; 1990 Mar; 4(1):1-10. PubMed ID: 2407775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.
    Altenburg AF; Magnusson SE; Bosman F; Stertman L; de Vries RD; Rimmelzwaan GF
    Clin Exp Immunol; 2017 Oct; 190(1):19-28. PubMed ID: 28665497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs.
    Magiri R; Lai K; Chaffey A; Zhou Y; Pyo HM; Gerdts V; Wilson HL; Mutwiri G
    Vaccine; 2018 Mar; 36(12):1606-1613. PubMed ID: 29454517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses induced by aqueous and emulsified influenza virus vaccines in mice exposed daily to x-rays.
    BERLIN BS
    J Immunol; 1962 Dec; 89():906-9. PubMed ID: 13970873
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant influenza-virus vaccines: II. Some properties of high-yielding recombinant influenza viruses and their vaccines.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Jun; 49(1-2):27-41. PubMed ID: 1025340
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serological study of the incidence of influenza A, B, C and adenoid-pharyngeal-conjuctival viruses in persons treated with emulsified influenza vaccine].
    BOEMI G; BALDUCCI D; MONGIA L
    Riv Ist Sieroter Ital; 1955; 30(5):336-43. PubMed ID: 13281369
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
    Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
    Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant influenza vaccines.
    Stuart-Harris CH
    Bull World Health Organ; 1969; 41(3):617-21. PubMed ID: 5309486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal delivery of a combination adjuvant comprising emulsified fine particles and LD-indolicidin enhances serological immunity to inactivated influenza virus.
    Huang MH; Dai SH; Chong P
    Microbes Infect; 2016 Nov; 18(11):706-709. PubMed ID: 27394146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.
    Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    Curr Opin Biotechnol; 2007 Dec; 18(6):529-36. PubMed ID: 18083548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory and clinical evaluation of new live influenza virus vaccines. Need for minimum requirements.
    Huygelen C
    Dev Biol Stand; 1977 Jun 1-3; 39():155-60. PubMed ID: 342307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in new vaccine strategies against influenza: a review].
    Liu Z; Jiang T; Qin E; Ran D; Qin C
    Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant influenza-virus vaccines. IV. Segregation of antigenic and some biological properties of Influenza virus neuraminidase by recombination.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Sep; 49(3):81-91. PubMed ID: 1029759
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influenza virus vaccines].
    Schell KR
    Schweiz Med Wochenschr; 1980 Apr; 110(14):510-22. PubMed ID: 6154970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant influenza-virus vaccines. III. Isolation and preliminary characterization of so-called antigenic recombinant influenza viruses.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Sep; 49(3):67-79. PubMed ID: 1029758
    [No Abstract]   [Full Text] [Related]  

  • 18. Recommended composition of influenza virus vaccines for use in the 2004-2005 influenza season.
    Wkly Epidemiol Rec; 2004 Feb; 79(9):88-92. PubMed ID: 15038066
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines.
    Galliher-Beckley A; Pappan LK; Madera R; Burakova Y; Waters A; Nickles M; Li X; Nietfeld J; Schlup JR; Zhong Q; McVey S; Dritz SS; Shi J
    Vaccine; 2015 Jun; 33(25):2903-8. PubMed ID: 25936722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic techniques for the production of influenza vaccines (author's transl)].
    Teti G
    Ann Sclavo; 1980; 22(1):34-9. PubMed ID: 7018413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.